Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market Report By Product (Alpha Blockers, 5-Alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitors And Others), Therapy (Monodrug Therapy And Combination Therapy) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210343
January 2019
Report Formats:
As per this study, the Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market was valued USD XXX MN (by revenue) in 2018 and is anticipated to reach USD XXX MN by 2025 with a CAGR of X.X%.
Benign prostatic hyperplasia (BPH) is the medical condition typically observed in old aged men characterized by enlargement of the prostate gland resulting into squeezing of the urethra. BPH can cause problems in the urinary bladder, kidney and urinary tract. It is often treated prescribing doses of alpha-blockers, 5-alpha reductase, or combination of other drugs. For severe conditions, minimally invasive or laser therapies are also performed to treat BPH.
Market Dynamics
The rise in elderly population along with the increasing prevalence of obesity, cardiovascular diseases, and erectile dysfunction are major factors driving the market growth. The rise in awareness regarding urological diseases is contributing to the growth of BPH and prostate treatment market. Also, growing preference to advanced treatment such as TURP, TUIP, TUMT and other minimally invasive techniques are likely to foster the market growth in the following timespan.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of benign prostatic hyperplasia (BPH) and prostate treatment.
Market Segmentation
The broad benign prostatic hyperplasia (BPH) and prostate treatment market has been sub-grouped into product and therapy. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Product
- Alpha Blockers
- 5-Alpha Reductase Inhibitor
- Phosphodiesterase-5 Inhibitors
- Others
By Therapy
- Monodrug Therapy
- Combination Therapy
Regional Analysis
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for benign prostatic hyperplasia (BPH) and prostate treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the benign prostatic hyperplasia (BPH) and prostate treatment market include Abbott Laboratories, Allergan plc, Astellas Pharma Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., Sanofi, and Teva Pharmaceutical Industries Limited. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.
1. INTRODUCTION
- Introduction To Benign Prostatic Hyperplasia (BPH) And Prostate Treatment
- Report Description
- Objectives Of The Study
- Assumptions
- Research Scope
- Research Methodology
- Data Source
2. EXECUTIVE SUMMARY
- Market Highlight
- Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market: Snapshot
3. MARKET ANALYSIS
- Drivers
- Restraints
- Opportunities
- Porter’s Five Forces Analysis
- Value Chain Analysis
4. BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY PRODUCT
- Market In Alpha Blockers
- Market In 5-Alpha Reductase Inhibitor
- Market In Phosphodiesterase-5 Inhibitors
- Market In Others
5. BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY THERAPY
- Market In Monodrug Therapy
- Market In Combination Therapy
6. BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT MARKET ANALYSIS BY GEOGRAPHY
- North America (NA)
- North America Market Estimates
- North America Market Estimates By Country
- United States (U.S.) Market Estimates By Segments
- Rest Of North America Market Estimates By Segments
- Europe (EU)
- Europe Market Estimates
- Europe Market Estimates By Country
- United Kingdom (UK) Market Estimates By Segments
- Germany Market Estimates By Segments
- France Market Estimates By Segments
- Rest Of Europe Market Estimates By Segments
- Asia Pacific (APAC)
- Asia Pacific Market Estimates
- Asia Pacific Market Estimates By Country
- China Market Estimates By Segments
- Japan Market Estimates By Segments
- India Market Estimates By Segments
- Rest Of Asia Pacific Market Estimates By Segments
- Latin America (LA)
- Latin America Market Estimates
- Latin America Market Estimates By Country
- Brazil Market Estimates By Segments
- Rest Of Latin America Market Estimates By Segments
- Middle East And Africa (MEA)
- Middle East And Africa Market Estimates
- Middle East And Africa Market Estimates By Country
- Middle East Market Estimates By Segments
- Africa Market Estimates By Segments
7. COMPETITIVE LANDSCAPE OF THE BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT COMPANIES
- Market Competition
- Partnerships/Collaborations/Agreements
- Mergers And Acquisitions
- New Product Launches
- Other Developments
8. COMPANY PROFILES OF THE BENIGN PROSTATIC HYPERPLASIA (BPH) AND PROSTATE TREATMENT INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
- Abbott Laboratories
- Allergan plc
- Astellas Pharma Inc.
- Boehringer Ingelheim Pharma GmbH & Co. KG
- Eli Lilly and Company
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Teva Pharmaceutical Industries Limited
* Tentative TOC
LIST OF TABLES
Table 1. Market Highlights Of Benign Prostatic Hyperplasia (BPH) And Prostate Treatment
Table 2. Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Product
Table 3. Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Therapy
Table 4. Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Geography
Table 5. North America Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Table 6. Europe Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Table 7. Asia Pacific Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Table 8. Latin America Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Table 9. Middle East And Africa Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
LIST OF FIGURES
Fig. 1. Market Segmentation Of Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Fig. 2. Top-Down Approach
Fig. 3. Bottom-Up Approach
Fig. 4. Market Highlights Of Benign Prostatic Hyperplasia (BPH) And Prostate Treatment
Fig. 5. Porter’s Five Forces Analysis
Fig. 6. Value Chain Analysis
Fig. 7. Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Product
Fig. 8. Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Therapy
Fig. 9. Global Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market By Geography
Fig. 10. North America Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Fig. 11. Europe Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Fig. 12. Asia Pacific Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Fig. 13. Latin America Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Fig. 14. Middle East And Africa Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Market
Fig. 15. Market Share Of Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Companies
Fig. 16. Recent Developments In Benign Prostatic Hyperplasia (BPH) And Prostate Treatment Industry
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
Objectives of Study
- Define and measure the global market
- Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
- Analyze and identify major market trends along with the factors driving or inhibiting the market growth
- Study the company profiles of the major market players with their market share
- Analyze competitive developments
Buy Chapters or Sections
Avail customized purchase options to meet your exact research needs:
- Buy sections of this report
- Buy country level reports
- Request for historical data
- Request discounts available for Start-Ups & Universities
